Ziopharm Oncology Reports Financial Results for Fourth Quarter and Full Year 2019
– Emergence of TCR program, Controlled IL-12 data, strengthened team highlight 2019 –– Balance sheet strengthened; cash of approximately $177 […]
uniQure and Gen-X Enter into Research Collaboration and License Agreement for the Development of Novel Synthetic Promoters
~ Gen-X Will Work with uniQure During an Exclusivity Period to Identify Novel Promoters for uniQure’s Product Portfolio ~~ uniQure […]
uniQure Announces 2019 Financial Results and Highlights Recent Company Progress
~ Patient Dosing Nearly Completed in Phase III HOPE-B Trial of Etranacogene Dezaparvovecin Hemophilia B ~~ First Patient Procedure in […]
StoneCo Reports Fourth Quarter and Fiscal Year 2019 Financial Results
GEORGE TOWN, Grand Cayman, March 02, 2020 (GLOBE NEWSWIRE) — StoneCo Ltd. (Nasdaq: STNE) (“Stone” or the “Company”), a leading […]
Everi Reports Record 2019 Fourth Quarter and Full Year Results
Company Initiates 2020 Full Year GuidanceBoard Authorizes $10 Million Share Repurchase ProgramLAS VEGAS, March 02, 2020 (GLOBE NEWSWIRE) — Everi […]
Integer Announces Retirement of Director Peter H. Soderberg
PLANO, Texas, March 02, 2020 (GLOBE NEWSWIRE) — Integer Holdings Corporation (“Integer”) (NYSE: ITGR) announced today that Peter H. Soderberg, […]
GenMark Diagnostics Announces Global Shipments of ePlex® RUO Test Kits Designed for SARS-CoV-2 Detection
CARLSBAD, Calif., March 02, 2020 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic […]
Nabriva Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DUBLIN, Ireland, March 02, 2020 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization […]
Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss 2019 Financial Results and Provide Corporate Update
BURNABY, British Columbia, March 02, 2020 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that […]
TSX News -
Financial 15 Split Corp. Extends Termination Date
TORONTO, March 02, 2020 (GLOBE NEWSWIRE) — Financial 15 Split Corp. (the “Company”) is pleased to announce it will extend […]
